SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
July, 2023
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x | Form 40-F ¨ |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ | No x |
If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.
EXHIBITS
Exhibit Number |
Description of Exhibits | |
99.1 | Intimation dated July 19, 2023 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
DR. REDDY’S LABORATORIES LIMITED (Registrant) | |||
Date: July 19, 2023 | By: | /s/ K Randhir Singh | |
Name: | K Randhir Singh | ||
Title: | Company Secretary |
Exhibit 99.1
Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad
- 500 034, Telangana, CIN : L85195TG1984PLC004507
Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.com |
July 19, 2023
National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sirs,
Sub: Intimation
This is to inform you that the United States Food & Drug Administration (USFDA) today completed a Pre-Approval Inspection (PAI) and a routine GMP inspection at our API manufacturing facility in Srikakulam, Andhra Pradesh, India (CTO-6). The inspection was conducted from 10th July, 2023 to 19th July, 2023. The inspection closed with zero observations and a classification of No Action Indicated (NAI).
Kindly take the above on your record.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
/s/ K Randhir Singh | |
K Randhir Singh | |
Company Secretary, Compliance Officer and Head CSR |
+/#XLE,FM,>U5
MW:7\+'#%T:Z0U)KL6U:LW+5T2&CZZ;ZM=@@HF$@L?N* =,/73;2.L8O^C;8.
M8:5^.Y%[^(N/F*N)WZA;%.(,)*'0Q]^!IJS)5]S(+2)Z7+6W#5E4F:PV?NEE
MGP,4P32=MT%5#F0*Z$@#[ZWW%U<7_"7-Y&* (MH9
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M@FY/EORLRJ9 2=]74N%2N -R@VBKC%-?^X&Q$GJ!!<(^ZB:?U%E>_E-+79M
M"46IX^?X2APJ4@%J5DL>=!LK1RK2YA*N"XZ1QX,HV